Lessons from biomedical technology regulation: North American and European comparisons1

Regulating Next Generation Agri-Food Biotechnologies: Lessons from European, North American and Asian Experiences

Volumn , Issue , 2013, Pages 164-181

  Engeli, Isabelle ^a   Allison, Christine Rothmayr ^b   Varone, Frédéric ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123158367     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203123324-22     Document Type: Chapter

References (42)

1. Abels, Gabriele and Christine Rothmayr (2007) ‘ART and GMO Policies in Germany:Effects of Mobilization, Issue-Coupling, and Europeanization’, in Éric Montpetit, Christine Rothmayr and Frédéric Varone (eds) The Politics of Biotechnology in North America and Europe. Lanham: Lexington (145-68).
2. Banchoff, T. (2005) ‘Path Dependence and Value-driven Issues. The Comparative Politics of Stem Cell Research’, World Politics, 57: 200-30.
3. Bauer, Martin W. (2005) ‘Distinguishing Red and Green Biotechnology: Cultivation Effects of the Elite Press’, International Journal of Public Opinion Research 17(1): 63-89.
4. Blank, Robert H. (2004) ‘The United Kingdom: Regulating Through a National Licensing Authority’, in Ivar Bleiklie, Malcolm L. Goggin and Christine Rothmayr (eds) Comparative Biomedical Policy. Governing Assisted Reproductive Technologies, London: Routledge (120-37).
5. Bleiklie, I., M. L. Goggin and C. Rothmayr (eds) (2004) Comparative Biomedical Policy. London: Routledge.
6. Bonnicksen, Andrea L. (2002) Crafting a Cloning Policy: from Dolly to Stem Cells. Washington, DC: Georgetown University Press.
7. Engeli, I. (2004) ‘France: Protecting Human Dignity while Encouraging Scientific Progress’, in I. Bleiklie, M. Goggin and C. Rothmayr (eds) Comparative Biomedical Policy: Governing Assisted Reproductive Technologies. London: Routledge.
8. Engeli, I. (2009) ‘The Challenges of Abortion and Assisted Reproductive Technologies Policies in Europe’, Comparative European Politics 7(1): 56-74.
9. Engeli, I. (2010) Les Politiques de la Reproduction. Paris: L’Harmattan.
10. Engeli, I. (2012) ‘Policy Struggle on Reproduction: Doctors, Women, and Christians’, Political Research Quarterly (forthcoming).
11. Engeli, I., C. Green-Pedersen and L. Thorup Larsen (2012) Morality Politics in Western Europe. Parties, Agenda and Policy Choices. London: Palgrave Macmillan.
12. Fink, S. (2008) ‘Politics as Usual or Bringing Religion Back In?: The Influence of Parties, Institutions, Economic Interests, and Religion on Embryo Research Laws’, Comparative Political Studies 41(12): 1631-56.
13. Garon, Francis and Éric Montpetit (2007) ‘Different Paths to the Same Result: Explaining Permissive Policies in the USA’, in Montpetit É., C. Rothmayr and F. Varone (eds) The Politics of Biotechnology in North America and Europe. Policy Networks, Institutions, and Internationalization. New York: Lexington.
14. Gaskell, G. and M. W. Bauer (eds) (2001) Biotechnology 1996-2000. The Years of Controversy. London: NMSI Trading Ltd.
15. Goggin, Malcolm L. and Deborah A. Orth (2004) ‘The United States National talk and state action in governing ART’, in Bleiklie, Ivar, Malcolm L. Goggin, and Christine Rothmayr (eds) Comparative Biomedical Policy: Governing Assisted Reproductive Technologies. Hove, East Sussex: Psychology Press (82-101).
16. Handyside A. H., E. H. Kontogianni, K. Hardy and R. M. Winston (1990) ‘Pregnancies from Biopsied Human Preimplantation Embryos Sexed by Y-specific DNA Amplification’, Nature, 344 (6268): 768-70.
17. Larsen, Lars Thorup, Donley T. Studlar and Christoffer Green-Pedersen (2012) ‘Morality Politics in the United Kingdom: Permissiveness in a Depoliticized Context’, in Isabelle Engeli, Christoffer Green-Pedersen and Lars Thorup Larsen (eds) Morality Politics in Western Europe: Parties, Agendas and Policy Choices. London: Palgrave Macmillan.
18. Linder, W. (1994) Swiss Democracy. Possible Solutions to Conflict in Multicultural Societies. Houndsmill: Macmillan.
19. Montpetit, Éric (2004) ‘Policy Networks, Federalism and Managerial Ideas: How ART Non-Decision in Canada Safeguards the Autonomy of the Medical Profession’, in Bleiklie, Ivar, Malcolm L. Goggin and Christine Rothmayr (eds) Comparative Biomedical Policy: Governing Assisted Reproductive Technologies. Hove, East Sussex:Psychology Press (64-81).
20. Montpetit, Éric (2007) ‘A Contrast of Two Sectors in the British Knowledge Economy’, in Éric Montpetit, Christine Rothmayr and Frédéric Varone (eds) The Politics of Biotechnology in North America and Europe: Policy Networks, Institutions, and Internationalization. Lanham: Lexington Books (103-22).
21. Montpetit, É. (2007) ‘The Canadian Knowledge Economy in the Shadow of the United Kingdom and the United States’, in É. Montpetit, C. Rothmayr and F. Varone (eds) The Politics of Biotechnology in North America and Europe. Policy Networks, Institutions, and Internationalization. Lanham: Lexington (83-102).
22. Montpetit, Éric, Christine Rothmayr and Frédéric Varone (2005) ‘Institutional Vulnerability to Social Constructions: Federalism, Target Populations and Policy Designs for Assisted Reproductive Technology in Six Democracies’ Comparative Political Studies 38(2): 119-42.
23. Montpetit, Éric, Christine Rothmayr and Frédéric Varone (eds) (2007) ‘Comparing Biotechnology Policy in Europe and North America: A Theoretical Framework’, in The Politics of Biotechnology in North America and Europe. New York: Lexington Books.
24. Papadopoulos, Y. (2001) ‘How Does Direct Democracy Matter? The Impact of Referendum Votes on Politics and Policy-Making’, West European Politics, 24(2): 35-58.
25. Pierson, P. (2000) ‘Increasing Returns, Path Dependence, and the Study of Politics’, American Political Science Review, 94(2): 251-67.
26. Pierson, Paul (2006) ‘Public Policies as Institutions’, in Ian Shapiro, Stephen Skowronek and Daniel Galvin (eds) Rethinking Political Institutions: The Art of the State. New York: New York University Press (114-31).
27. Ramjoué, Celina and Ulrich Köti (2004) ‘Art Policy in Italy: Explaining the Lack of Comprehensive Regulation’, in: Ivar Bleiklie, Malcolm Goggin and Christine Rothmayr (eds) Comparative Biomedical Policy. London: Routledge (42-63).
28. Rose, R. and P. L. Davies (1993) Inheritance in Public Policy. Change without Choice in Britain. Yale University Press.
29. Rothmayr, Christine (2003) ‘Regulatory Approaches to Biomedicine: the Impact of Selfregulation on the Public Policies for Assisted Reproductive Technology’, in U. Serdült and T. Widmer (eds) Politik im Fokus, Festschrift für Ulrich Klöti: 425-45. Zürich:NZZ Verlag.
30. Rothmayr, Christine (2006) ‘Explaining Restrictive ART Policies in Switzerland and Germany: Similar Processes - Similar Results?' German Policy Studies 3(4): 595-647.
31. Rothmayr, Christine (2007) ‘Switzerland: Direct Democracy and Non-EU Membership -Different Institutions, Similar Policies’, in: Éric Montpetit, Christine Rothmayr and Frédéric Varone (eds) The Politics of Biotechnology in North America and Europe. Lanham: Lexington (237-61).
32. Rothmayr, Christine and Celina Ramjoué (2004) ‘Germany: ART Policy as Embryo Protection’, in Ivar Bleiklie, Malcolm Goggin and Christine Rothmayr (eds) Comparative Biomedical Policy: Governing Assisted Reproductive Technologies. London: Routledge (174-90).
33. Rothmayr, Christine and Uwe Serdült (2004) ‘Switzerland: Policy Design and Direct Democracy’, in: Ivar Bleiklie, Malcolm Goggin and Christine Rothmayr (eds) Comparative Biomedical Policy: Governing Assisted Reproductive Technologies. London: Routledge (191-208).
34. Rothmayr, Christine and Frédéric Varone (2009) ‘Direct Legislation in North America and Europe: Promoting or Restricting Biotechnology?', Journal of Comparative Policy Analysis: Research and Practice, 11(4): 425-49.
35. Rothmayr, C., F. Varone, U. Serdült, A. Timmermans and I. Bleiklie (2004) ‘Comparing Policy Design across Countries: What accounts for Variation in ART policy?', in I. Bleiklie, M. Goggin and C. R. Rothmayr (eds) Comparative Biomedical Policy:Governing Assisted Reproductive Technologies. London: Routledge (228-53).
36. Scala, F. (2003) ‘Experts, embryons et "économie d’innovation”: la recherche sur les cellules souches dans le discours politique au Canada’, Lien social et Politiques 50: 75-80.
37. Schiffino, Nathalie, Célina Ramjoué and Frédéric Varone (2009) ‘Biomedical Policies in Belgium and Italy: From Regulatory Reluctance to Policy Changes’, West European Politics, 32(3): 559-85.
38. Timmermans, Arco (2004) ‘The Netherlands: Conflict and Consensus on ART Policy’, in Ivar Bleiklie, Malcolm L. Goggin and Christine Rothmayr (eds) Comparative Biomedical policy. Governing Assisted Reproductive Technologies. London: Routledge (155-73).
39. Timmermans, Arco (2007) ‘Accommodation, Bureaucratic Politics, and Supranational Leviathan: ART and GMO Policy-Making in the Netherlands’, in Éric Montpetit, Christine Rothmayr and Frédéric Varone (eds) The Politics of Biotechnology in North America and Europe: Policy Networks, Institutions, and Internationalization. Lanham:Lexington Books (169-92).
40. Timmermans, Arco and Peter Scholten (2006) ‘The Political Flow of Wisdom: Science Institutions ad Policy Venues in the Netherlands’, Journal of European Public Policy 13(7): 1104-18.
41. Varone, Frédéric and Nathalie Schiffino (2004) ‘Regulating Biotechnologies in Belgium. Diverging Designs for ART and GMOs’, Archives of Public Health, 62: 83-106.
42. Varone, Frédéric, Christine Rothmayr and Éric Montpetit (2006) ‘Regulating Biomedicine in Europe and North America: A Qualitative Comparative Analysis’, European Journal of Political Research 45: 317-43.